Analysis of the clinicopathologic features of tumors in 2 GSE datasets (GSE126964 and GSE73731) revealed that decreased FBXO7 expression was associated with increased tumor stage and grade (T3/T4, G3/G4, and Stage III/IV) (Fig. 4B). Here, FBXO7 is linked to neoplasm.